Adam D. Levy serves as Executive at Acrivon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Adam D. Levy has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 1, 2025 involved selling 1,164 shares valued at $1.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 1, 2025 | ACRV | $1.5K | Payment | 1,164 | $1.26 | Discretionary |
Adam D. Levy currently holds 12,151 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam D. Levy has been a net neutral trader of ACRV stock. They have purchased $0 and sold $0 worth of shares.
Adam D. Levy's most recent insider trade was on Aug 1, 2025, when they sold 1,164 shares at $1.26 per share.
Get notified when new Form 4 filings are submitted